Drugs / Ag85B-ESAT6 fusion protein H1
last change Feb 2008 re-read 3 minutes ago

Ag85B-ESAT6 fusion protein H1

Vaccine

Developed for
tuberculosis
Investigated by
European Union · Novartis Vaccines · St George's, University of London · Statens Serum Institut

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00440544 Jan → Nov 2007 tuberculosis St George's, University of London Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ag85B-ESAT6 fusion protein H1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00440544 ↗
Modality Vaccine “subunit tuberculosis vaccine” NCT00440544 ↗
Route Intranasal “two nasal immunizations” NCT00440544 ↗